The type I fusion involving FGFR1 and the FGFR1 oncogene partner (FOP) is associated with a stem cell myeloproliferative disorder, acute myeloid leukemia (AML) [220,221,222,223,224,225,226,227] (Table 1). Here, FGFR1 is linked to acute myeloid leukemia.